Evidence map›Paper›PMID 36568384›Full record

ArticleFrontiers in genetics2022

Comprehensive analysis of a novel cuproptosis-related lncRNA signature associated with prognosis and tumor matrix features to predict immunotherapy in soft tissue carcinoma.

Binfeng Liu, Ke Pang, Chengyao Feng, Zhongyue Liu, Chenbei Li, Haixia Zhang, Ping Liu, Zhihong Li, Shasha He, Chao Tu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Binfeng LiuDepartment of Orthopaedics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Ke PangDepartment of Orthopaedics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Chengyao FengDepartment of Orthopaedics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Zhongyue LiuDepartment of Orthopaedics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Chenbei LiDepartment of Orthopaedics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Haixia ZhangDepartment of Oncology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Ping LiuDepartment of Oncology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Zhihong LiDepartment of Orthopaedics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Shasha HeDepartment of Oncology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Chao TuDepartment of Orthopaedics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Second Xiangya Hospital of Central South University · CNCentral South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cuproptosislncRNAsignaturesoft tissue sarcomatumor immune microenvironment

Identifiers

PMID36568384
PMCPMC9768346
OpenAlexW4311707724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.